Antidepressant use during pregnancy: Comparison of data obtained from a prescription register and from antenatal care records

European Journal of Clinical Pharmacology

Volumn 67, Issue 8, 2011, Pages 839-845

  Källén, Bengt ^a   Nilsson, Emma ^b   Olausson, Petra Otterblad ^b  

^a UNIVERSITY OF LUND   (Sweden)

^b NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

Author keywords

Antidepressants; Interview data; Pharmacoepidemiology; Prescription register

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM;

ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG MONITORING; DRUG SAFETY; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MEDICAL RECORD; MENSTRUAL CYCLE; NEWBORN ASSESSMENT; PHARMACOEPIDEMIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MEDICAL RECORDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTERS; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; REGISTRIES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SWEDEN;

EID: 79960940164     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1021-8     Document Type: Article

References (15)

1. Källén B (2005) Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom 45:44-51
2. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335:1010-1015
3. McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Mastroiacovo P, Arnon J, Rodriguez-Pinilla E, Schaefer C, Pexieder T, Merlob P, Dal Verme S (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 10:285-294
4. Diav-Citrin O, Schechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A (2008) Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66:695-705
5. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C (2008) Effect of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 192:338-343 (Pubitemid 351692377)
6. Cole JA, Ephross SA, Cosmatos IS, Walker AM (2007) Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 16:1075-1085 (Pubitemid 350020060)
7. Malm H, Klaukka T, Neuvonen PJ (2005) Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 106:1289-1296 (Pubitemid 41668948)
8. Wogelius P, Norgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, Lipworth L, Sørensen HT (2006) Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 17:701-704 (Pubitemid 44655607)
9. Pedersen LH, Henriksen TB, Vestergaard M, Olsen J (2009) Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339:b3569
10. Espnes MG, Bjørge T, Engeland A (2011) Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 20:243-248
11. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H (2011) Drug use during pregnancy in Sweden-assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol 3:43-50
12. National Board of Health and Welfare, Centre for Epidemiology (2003) The Swedish Medical Birth Registry - a summary of content and quality. Available at: http://www.sos.se/publikationer2003/2003-112-3
13. Reis M, Källén B (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 10:1723-1733
14. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726-735 (Pubitemid 47180362)
15. Källén B, Otterblad Olausson P (2001) Monitoring of maternal drug use and infant congenital malformations: does loratadine cause hypospadias? Int J Risk Saf Med 14:115-119